Emerging Trends in Medical Devices: Mobile Health, Personalized Medicine and Consumerization-2010-09-27

Event Information
Event Name: 
Emerging Trends in Medical Devices: Mobile Health, Personalized Medicine and Consumerization
Event Date: 
09/27/2010 - 5:30pm
Event Location: 
UCSC Extension, 2505 Augustine, Santa Clara
Event Details
Event Type: 
Panel Discussions
Event Details: 

Life Science Entrepreneurs' Forum

Emerging Trends in Medical Devices:
Mobile Health, Personalized Medicine and Consumerization

UCSC Extension, 2505 Augustine, Santa Clara
September 27
5:30 p.m. - 7:30 p.m.
FountainBlue's Life Science Entrepreneurs' Forum

Emerging Trends in Medical Devices: Mobile Health, Personalized Medicine and Consumerization

Date & Time: Monday, September 27 from 5:30 to 7:30 p.m.

Location: UCSC Extension, 2505 Augustine, Santa Clara

Pre-registration Cost: $21 members, $32 partners, $42 general

Late and On-Site Registration is $42 for members, $52 for nonmembers, or $124 for FountainBlue Ongoing membership and admission

Registration: Please pre-register by noon on Friday, September 24 using the PayPal link at http://www.svlifescience.com.

Audience: Life Science entrepreneurs, intrapreneurs and investors; no service providers please

Emerging Trends in Medical Devices - Mobile Health, Personalized Medicine and Consumerization

Our annual state of the medical device industry event will focus on some of the hottest areas in medical devices today: from mobile health solutions to personalized medicine and consumer devices. Come hear about these hot new trends, and see how start-ups are leading medical device innovations around mobile health and personalized medicine, bringing devices into the hands of consumers.

Facilitator Geetha Rao, PhD, Springborne Life Sciences

Panelist Anne DeGheest, Managing Director and Founder, HealthTech Capital, Managing Partner and Founder

MedStars
Dave Scott, Director, Imaging Systems, Intuitive Surgical, Inc
Clarence Wilhelm, LifeScan, to be confirmed
Marc Bandt, CEO, Pelesend
Personalized Medicine
Diagnostic for Consumers

Facilitator Geetha Rao, PhD, CEO, MyMedFax and Springborne Life Sciences, Vice President of Strategy and Risk Management, Triple Ring Technologies

Dr. Geetha Rao's over 20 years of experience in high-risk technologies includes being an entrepreneur, executive and strategic advisor to numerous early-stage life sciences ventures. She is the founding CEO of Springborne Life Sciences, providing advisory services and interim management to medical device, biotechnology and other life-sciences enterprises with a focus on emerging business challenges and operational excellence that meets best-in-class, international standards. She serves as Vice President of Strategy and Risk Management at Triple Ring Technologies, a medical device incubator and contract development firm. She is an internationally recognized expert in risk management and liability and has served on several international policy making bodies, and as an invited expert to regulatory agencies, including the FDA.

Geetha chairs the MIT/Stanford Venture Lab's Emerging Business Track for Life Sciences, serves on the Life Sciences Committee for Astia, the leading organization supporting women-founded and women-led start-ups, and has been a guest faculty on Stanford University's Biodesign Innovation Program. She is a graduate of the Indian Institute of Technology, Madras, holds a doctorate from MIT and a masters degree from Stanford University's Graduate School of Business, where she was a Sloan Fellow.

Panelist Anne DeGheest, Managing Director and Founder, HealthTech Capital and Managing Partner and Founder, MedStars

Anne has 25 years investing experience with MedStars, and has been a pioneer investor in the field of HealthTech. Companies in which Anne has invested have raised over $500 million in venture capital and grew to $6 billion market cap. Anne has been a mentor capitalist specializing in investing and mentoring early-stage start-ups in healthcare companies including Pyxis (CareFusion), Aspect Medical (acquired by Covidien), VISX (acquired by AMO), Thermage (merged into Solta Medical), VISICU(acquired by Philips), Masimo (Nasdaq: MASI). She also helped grow new entrepreneurial division of large corporations like Johnson & Johnson, Baxter, Medtronic and McKesson. She was also part of the founding executive team of Nellcor (a division of Covidien), MedPool and OmniCell (Nasdaq: OMCL). Anne earned an MS, Brussels and an MBA, Harvard.

Panelist Dave Scott, Director, Imaging Systems, Intuitive Surgical

Dave Scott is the Senior Product Manager for Vision and Medical Imaging at Intuitive Surgical. He has spent the last 15 years in research and development related to medical imaging and diagnostics. Dave spent several years developing novel medical imaging solutions for the Medical Technology Program and Center for Advanced Signal and Imaging Sciences at Lawrence Livermore National Lab. At LLNL he worked on next generation breast cancer screening systems utilizing ultrasound tomography and acoustic scanning systems for prosthetic heart valve assessment. He was part of the core start-up team at Xradia, Inc where he was awarded an R&D100 award for the development of the Nano-XCT, a 50nm resolution x-ray tomography system. He is a co-founder of Varioscale, Inc, a start-up venture dedicated to bringing ultra-high resolution laser etching technology to the semiconductor and life science communities for "lab-on-a-chip" applications.

Currently, Dave is dedicated to identifying advanced imaging technologies for the daVinci Robotic surgical platform through the development of technology partnerships and internal research efforts. His experience in medical device R&D along with his startup experiences allow him to provide invaluable feedback and guidance for early stage ventures. He regularly works with start-up companies developing strategies for technology development and product positioning for acquisition or licensing. Dave holds a BS in Aerospace engineering from the University of Kansas and an MS in Aerospace/Medical Engineering from the University of Colorado, Boulder.

Presenting Entrepreneur Marc Bandt, CEO, Pelesend Inc.

Marc has raised initial and follow-up funding for initial product development on several occasions. His run rate for current start-up over the next 12 months is to exceed $500,000 with cash-flow break-even achieved within the first 18 months of founding. Marc specializes in the use of high technology in health care although considered an experienced silicon valley generalist when it comes to marketing, product development, and technology use. He applies extensive experience in launching, developing and maturing software and hardware companies with an emphasis on the use of the latest "tools" in health care and it's associated organizations.
Marc has raised money, written and executed business plans, established and supported the corporate message to customers, potential investors and business partners, identified suitable technologies and directed their use against business goals. He earned his BS from Southern Methodist University and his MBA from Cox School of Business MBA.